Group 1 - On September 15, BeiGene's stock increased by 1.40%, with a trading volume of 2.1 billion yuan [1] - The financing data shows that on the same day, BeiGene had a financing purchase amount of 241 million yuan and a financing repayment of 231 million yuan, resulting in a net financing purchase of 10.32 million yuan [1] - As of September 15, the total balance of margin trading for BeiGene was 1.334 billion yuan, with a financing balance of 1.314 billion yuan, accounting for 3.57% of the circulating market value, which is above the 90th percentile level over the past year [1] Group 2 - As of June 30, the number of BeiGene shareholders was 23,300, a decrease of 3.90% from the previous period, while the average circulating shares per person increased by 4.11% to 4,976 shares [2] - For the first half of 2025, BeiGene achieved operating revenue of 17.518 billion yuan, a year-on-year increase of 46.03%, and a net profit attributable to shareholders of 450 million yuan, up 115.63% year-on-year [2] - In terms of institutional holdings, as of June 30, 2025, the top ten circulating shareholders included several notable funds, with changes in their holdings indicating varying levels of investment interest [2]
百济神州9月15日获融资买入2.41亿元,融资余额13.14亿元